These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36650542)

  • 1. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer.
    Bian Y; Yu Y; Wang S; Li L
    Biochem Biophys Res Commun; 2015 Aug; 463(4):612-7. PubMed ID: 26043686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
    Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
    Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Migita T; Ruiz S; Fornari A; Fiorentino M; Priolo C; Zadra G; Inazuka F; Grisanzio C; Palescandolo E; Shin E; Fiore C; Xie W; Kung AL; Febbo PG; Subramanian A; Mucci L; Ma J; Signoretti S; Stampfer M; Hahn WC; Finn S; Loda M
    J Natl Cancer Inst; 2009 Apr; 101(7):519-32. PubMed ID: 19318631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma.
    Ishida CT; Myers SL; Kubota CS; Shao W; McGuire MR; Liu C; Ewachiw TE; Mukhopadhyay D; Ke S; Wang H; Rasheed ZA; Anders RA; Espenshade PJ
    Cancer Res Commun; 2024 Sep; 4(9):2539-2552. PubMed ID: 39240063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
    Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
    Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experiments.
    Zheng Y; Xiong Q; Yang Y; Ma Y; Zhu Q
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):318. PubMed ID: 38914714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.
    Karantanos T; Karanika S; Wang J; Yang G; Dobashi M; Park S; Ren C; Li L; Basourakos SP; Hoang A; Efstathiou E; Wang X; Troncoso P; Titus M; Broom B; Kim J; Corn PG; Logothetis CJ; Thompson TC
    Oncotarget; 2016 Jul; 7(29):46321-46334. PubMed ID: 27331874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.
    Cao Z; Xu Y; Guo F; Chen X; Ji J; Xu H; He J; Yu Y; Sun Y; Lu X; Wang F
    Dis Markers; 2020; 2020():3904947. PubMed ID: 32655718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
    Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T
    PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer.
    Dairo O; DePaula Oliveira L; Schaffer E; Vidotto T; Mendes AA; Lu J; Huynh SV; Hicks J; Sowalsky AG; De Marzo AM; Joshu CE; Hanratty B; Sfanos KS; Isaacs WB; Haffner MC; Lotan TL
    Cancer Res Commun; 2024 Jan; 4(1):152-163. PubMed ID: 38112617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome reveals the heterogeneity of malignant ductal cells and the prognostic value of REG4 and SPINK1 in primary pancreatic ductal adenocarcinoma.
    Ji Y; Xu Q; Wang W
    PeerJ; 2024; 12():e17350. PubMed ID: 38827297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.
    Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X
    Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
    Li S; Yan G; Yue M; Kang Z; Wang L
    Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.
    Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G
    Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.